Stocktoria
Black Hawk Acquisition Corp BKHA
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2024-03-21
Black Hawk Acquisition Corp financials (annual, from 10-K)
| Metric | FY2025 | FY2024 |
|---|---|---|
| Operating income | -$915,510 | -$576,076 |
| Interest expense | $15,454 | — |
| Net income | $1.3M | $1.9M |
| Operating cash flow | -$650,321 | -$553,665 |
| Cash & equivalents | $0 | $0 |
| Total assets | $23.9M | $72.1M |
| Total liabilities | $3.9M | $2.5M |
| Shareholders' equity | -$3.8M | -$2.2M |
Source: SEC EDGAR filings · CIK 0002000775 · as of 2025-11-30. Facts from filings plus Stocktoria's own computed scores — not investment advice.